DERMA PHARM A/S: Financial statements 2022
CVR: 89453119
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 71,192,456 and a net result of DKK 4,022,422 compared with DKK 7,227,010 the year before. That is an increase of 0.8% compared with the year before. Equity in the 2022 report amounted to DKK 39,529,070. The solvency ratio was 32.3%. The company had 121 employees in the financial year.
- Gross Profit
- DKK 71,192,456
- Profit/Loss
- DKK 4,022,422
- Equity
- DKK 39,529,070
- Total Assets
- DKK 122,539,287
- Employees
- 121
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 71.2 mio. | 4 mio. | 39.5 mio. | 121 |
| 2021 | - | 70.7 mio. | 7.2 mio. | 39.6 mio. | 115 |
| 2020 | - | 76.2 mio. | 12 mio. | 40.5 mio. | 108 |
| 2019 | - | 63.5 mio. | 6.1 mio. | 32.6 mio. | 105 |
| 2018 | - | 52.4 mio. | 4.6 mio. | 30.7 mio. | 91 |
Official annual report
Keep an eye on DERMA PHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
DERMA PHARM A/S has published its annual report for 2021. Gross profit came to DKK 70,656,820, and the net result was DKK 7,227,010.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.